Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
Luxiang Wang, Chunli Zhang, Shuang Fan, Xiao‐Dong Mo, Xiaoxia Hu
Topics & Concepts
ChemotherapyMedicineOncologyIntensive care medicineInternal medicineAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell Transplantation